Skip to content

Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial(Ⅱ)

Efficacy and Mechanism of Repeated Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorder: an Open-label Clinical Trial(Ⅱ)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05472870
Enrollment
30
Registered
2022-07-25
Start date
2022-07-12
Completion date
2023-01-20
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Keywords

Repetitive Transcranial Magnetic Stimulation(rTMS), Continuous theta Burst Stimulation (cTBS)

Brief summary

This study is a open-label clinical trial involving over 30 ASD children aged ≥4 years old. During the study, subjects received repeated transcranial magnetic stimulation (rTMS) intervention on the left primary motor cortex (M1) 10 times per day for 5 consecutive days and complete clinical assessments from pre-intervention to post-intervention. This study hopes to explore whether accelerated continuous theta-burst stimulation (a-cTBS) over left primary motor cortex (M1) can improve clinical symptoms of children with ASD in China.

Detailed description

This study is a single-arm open-label clinical trial, designed to enroll at least 30 children with ASD aged over 4 years old. During the trial, participants will receive accelerated continuous theta-burst stimulation (a-cTBS)on the left primary motor cortex (M1) for 5 consecutive days and complete clinical assessments within 2 weeks before the cTBS intervention (pre-cTBS), repeated within 3 days after the completion of the cTBS course (post-cTBS) and 1 month following the last cTBS session (one month follow-up), respectively. The purpose of this current study is to explore whether rTMS can improve the clinical symptoms of children with autism spectrum disorder in China, and to investigate the neurophysiological mechanism of rTMS for ASD children.

Interventions

DEVICErepetitive Transcranial Magnetic Stimulation

A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the cerebral cortex.

Sponsors

Shanghai Mental Health Center
CollaboratorOTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Children aged ≥4 years. * Meeting the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Edition 5 (DSM-5) . * Confirmed by the ADOS and/or ADI-R diagnostic tool. * Informed consent.

Exclusion criteria

* Patients with metal implants . * Patients with neurological diseases such as epilepsy . * Patients requiring surgical treatment due to structural abnormalities indicated by brain MRI . * Genetic or chromosomal abnormalities . * Suffering from mental disorders (such as mood disorders, etc.) * Suffering from serious heart disease . * Hearing-impaired . * Intracranial hypertension . * Participating in other clinical trials. * Participants who received other interventions within 4 weeks prior to enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Social Response Scale (SRS) ScoresBaseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.Social Response Scale (SRS) is a parent questionnaire used to assess the presence and severity of social impairment. The SRS generates a total score and five subscale scores (social awareness, social cognition, social communication, social motivation, and autistic mannerisms), and 5 subscales scores are summed to compute the total score; higher scores indicate greater social impairment. The SRS total score range is 0-195, the social awareness subscale score range is 0-24, the social cognition subscale score range is 0-36, the social communication subscale score range is 0-66, the social motivation subscale score range is 0-33, and the autistic mannerisms subscale score range is 0-36. We collected the SRS from baseline to 1 month follow-up to evaluate the effect of rTMS treatment on ASD syptoms among these children.

Secondary

MeasureTime frameDescription
Childhood Autism Rating Scale (CARS)Baseline, and 4 weeks after the completion of intervention.CARS is a behaviour-rating scale used to assess the presence and severity of the symptoms of autism spectrum disorder(ASD), with scores ranging from 15 to 60 and high scores indicating severe symptoms. Change of the CARS from baseline to 1 months after treatment to evaluate the effect of rTMS treatment on ASD. children.
Behavior Rating Inventory of Executive Function (BRIEF)Baseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.BRIEF is a quick and efficient measure of executive function(have school-age version (BRIEF-S) and preschool version (BRIEF-P)), we asked parents to complete the 86-item (BRIEF-S) or 63-item (BRIEF-P) form to rate a child's executive functions (1-3 score) within the context of his everyday environments (home or school). Here we report the BRIEF composite score, BRIEF-S score range is 86 -258 and BRIEF-P score range is 63-189. The higer scores indicate more impairment in executive function. We evaluate the changes in executive function (EF) scores before and after cTBS treatment.
Conners Parent Symptom Questionnaire (PSQ)Baseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.Conners Parent Symptom Questionnaire (PSQ) is a questionnaire screening for children's behavioral problems (especially with ADHD), it has 48 items(4-stage: 0-3) that can be divided into 6 factors (conduct problems, learning problems, psychosomatic problems, impulsive-hyperactivity, anxiety, and hyperactivity index). Add the scores and divide by the item numbers of each factor to get Z score. Here we mainly observe the changes in Hyperactivity Index (HI) Z scores, it ranges from 0-3, a higher score mean a worse outcome.
Peabody Picture Vocabulary Test(PPVT)Baseline, and 4 weeks after the completion of intervention.The Peabody Picture Vocabulary Test is one of the most commonly used assessment tests for measuring single-word comprehension. The raw score ranges from 0-110, the higher scores mean a better outcome. we collected the PPVT raw score from baseline to 1 months after treatment to evaluate the effect of rTMS treatment on ASD children's words comprehension.
Clinical Global Impression of Improvement (CGI-I)After the completion of 5-days intervention and 4 weeks after the completion of intervention.CGI is a scale used to assess the severity of the illness and the global improvement of the patient under intervention. Here we used Clinical Global Impression of Improvement (CGI-I) to rate how much the patient's illness has improved or worsened relative to baseline (a seven-point scale: 1 = very much improved to 7 = very much worse). The CGI was carried out by trained clinical assessors according to children's CARS、ADOS assessment results and parent interviews before and after intervention. We calculated the number of subjects with improvement (CGI-I≤3).
Repetitive Behaviors Scale - Revised (RBS-R)baseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.The Repetitive Behaviors Scale - Revised (RBS-R) is a 44-item (rated 0-3) questionnaire that is used to measure the breadth of repetitive behavior in children, adolescents, and adults with Autism Spectrum disorders. The RBS-R provides a quantitative, continuous measure of the full spectrum of repetitive behaviors. The RBS-R consists of six subscales including: Stereotyped Behavior, Self-injurious Behavior, Compulsive Behavior, Routine Behavior, Sameness Behavior, and Restricted Behavior, that have no overlap of item content. Here we use the RBS-R total score, it ranges from 0-132, the higher score means worse repetitive behavior.
Chinese Communicative Development Inventory (CCDI)Baseline and 4 weeks after the completion of intervention.CCDI provides a powerful tool to assess early vocabulary development and the language skills of older children with developmental disorders and the effectiveness of their intervention. Here we collected the CCDI words produced score, it ranges from 0-798. The higher scores mean a better outcome.

Other

MeasureTime frameDescription
Power Spectral Density (PSD) Within the Alpha Frequency BandBaseline, immediately after the completion of 5-days intervention.For EEG data, we caculated the power spectral density (PSD) within the alpha frequency band (8-13 Hz) for all channels.
Multilingual Assessment Instrument for Narratives (MAIN)Baseline, and 4 weeks after the completion of intervention.For a subset of ASD children with adequate expressive ability (those able to at least use phrases), we use Multilingual Assessment Instrument for Narratives (MAIN) tool to assess their narrative comprehension and production skills. In this test, children were asked to tell and retell the story and answer comprehension questions, and then assessors scored children's performance from four dimensions (i.e., story structure, structural complexity, and internal state terms and comprehension questions). The story structure score range is 0-18, structural complexity score range is 0-4, internal state terms score range is 0-no limit, and comprehension questions score range is 0-10. The higher score means better performance.

Countries

China

Participant flow

Participants by arm

ArmCount
rTMS Group
Participants will receive accelerated continuous theta burst stimulation (a-cTBS, i.e. triplet standard cTBS, 1800 pulses/120s) for a 5 consecutive days, at an intensity that is 80% of the resting motor threshold (RMT) . a-cTBS repeats ten times a day with about 50 min interval . If feasible for the participant, all stimulation sessions will be held at the same time of the day. Treatment will be applied in left primary motor cortext (M1).
30
Total30

Baseline characteristics

CharacteristicrTMS Group
Age, Continuous7.06 years
STANDARD_DEVIATION 1.55
Autism Diagnostic Observation Schedule (ADOS)13.73 units on a scale
STANDARD_DEVIATION 2.74
Childhood Autism Rating Scale (CARS)33.48 units on a scale
STANDARD_DEVIATION 2.59
Full Scale intelligence quotient (FSIQ)74.97 units on a scale
STANDARD_DEVIATION 24.7
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
30 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
China
30 participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
24 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
8 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Social Response Scale (SRS) Scores

Social Response Scale (SRS) is a parent questionnaire used to assess the presence and severity of social impairment. The SRS generates a total score and five subscale scores (social awareness, social cognition, social communication, social motivation, and autistic mannerisms), and 5 subscales scores are summed to compute the total score; higher scores indicate greater social impairment. The SRS total score range is 0-195, the social awareness subscale score range is 0-24, the social cognition subscale score range is 0-36, the social communication subscale score range is 0-66, the social motivation subscale score range is 0-33, and the autistic mannerisms subscale score range is 0-36. We collected the SRS from baseline to 1 month follow-up to evaluate the effect of rTMS treatment on ASD syptoms among these children.

Time frame: Baseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.

ArmMeasureGroupValue (MEAN)Dispersion
rTMS GroupSocial Response Scale (SRS) ScoresPre-intervention94.27 score on a scaleStandard Deviation 20.26
rTMS GroupSocial Response Scale (SRS) ScoresPost-intervention81.50 score on a scaleStandard Deviation 21.27
rTMS GroupSocial Response Scale (SRS) Scores1month follow-up77.67 score on a scaleStandard Deviation 20.13
Comparison: All clinical behavioral data analysis was performed using Statistical Product and Service Solutions (SPSS) software (version 25.0). A P value \<0.05 was considered statistically significant for all analyses. One-way ANOVA with repeated measures was used to examine differences in the effects of cTMS on the SRS.p-value: <0.001ANOVA
Secondary

Behavior Rating Inventory of Executive Function (BRIEF)

BRIEF is a quick and efficient measure of executive function(have school-age version (BRIEF-S) and preschool version (BRIEF-P)), we asked parents to complete the 86-item (BRIEF-S) or 63-item (BRIEF-P) form to rate a child's executive functions (1-3 score) within the context of his everyday environments (home or school). Here we report the BRIEF composite score, BRIEF-S score range is 86 -258 and BRIEF-P score range is 63-189. The higer scores indicate more impairment in executive function. We evaluate the changes in executive function (EF) scores before and after cTBS treatment.

Time frame: Baseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.

Population: Three parents of participants did not complete the questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
rTMS GroupBehavior Rating Inventory of Executive Function (BRIEF)Pre-intervention153.76 score on a scaleStandard Deviation 20.55
rTMS GroupBehavior Rating Inventory of Executive Function (BRIEF)Post-intervention152.76 score on a scaleStandard Deviation 20.28
rTMS GroupBehavior Rating Inventory of Executive Function (BRIEF)1month follow-up149.12 score on a scaleStandard Deviation 18.35
rTMS Group (Preschool Age)Behavior Rating Inventory of Executive Function (BRIEF)Pre-intervention115.30 score on a scaleStandard Deviation 10.09
rTMS Group (Preschool Age)Behavior Rating Inventory of Executive Function (BRIEF)Post-intervention117.60 score on a scaleStandard Deviation 14.24
rTMS Group (Preschool Age)Behavior Rating Inventory of Executive Function (BRIEF)1month follow-up112.00 score on a scaleStandard Deviation 10.59
Secondary

Childhood Autism Rating Scale (CARS)

CARS is a behaviour-rating scale used to assess the presence and severity of the symptoms of autism spectrum disorder(ASD), with scores ranging from 15 to 60 and high scores indicating severe symptoms. Change of the CARS from baseline to 1 months after treatment to evaluate the effect of rTMS treatment on ASD. children.

Time frame: Baseline, and 4 weeks after the completion of intervention.

ArmMeasureGroupValue (MEAN)Dispersion
rTMS GroupChildhood Autism Rating Scale (CARS)pre-intervention33.48 score on a scaleStandard Deviation 2.59
rTMS GroupChildhood Autism Rating Scale (CARS)1month follow-up32.83 score on a scaleStandard Deviation 2.66
Secondary

Chinese Communicative Development Inventory (CCDI)

CCDI provides a powerful tool to assess early vocabulary development and the language skills of older children with developmental disorders and the effectiveness of their intervention. Here we collected the CCDI words produced score, it ranges from 0-798. The higher scores mean a better outcome.

Time frame: Baseline and 4 weeks after the completion of intervention.

Population: 8 subjects whose parents did not complete the follow-up scale or who had reached the highest measurable score on the scale in terms of ability (ceiling effect) were not included in the analysis

ArmMeasureGroupValue (MEAN)
rTMS GroupChinese Communicative Development Inventory (CCDI)Pre-intervention733.00 score on a scale
rTMS GroupChinese Communicative Development Inventory (CCDI)1month follow-up771.50 score on a scale
Secondary

Clinical Global Impression of Improvement (CGI-I)

CGI is a scale used to assess the severity of the illness and the global improvement of the patient under intervention. Here we used Clinical Global Impression of Improvement (CGI-I) to rate how much the patient's illness has improved or worsened relative to baseline (a seven-point scale: 1 = very much improved to 7 = very much worse). The CGI was carried out by trained clinical assessors according to children's CARS、ADOS assessment results and parent interviews before and after intervention. We calculated the number of subjects with improvement (CGI-I≤3).

Time frame: After the completion of 5-days intervention and 4 weeks after the completion of intervention.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
rTMS GroupClinical Global Impression of Improvement (CGI-I)Post-intervention20 Participants
rTMS GroupClinical Global Impression of Improvement (CGI-I)1month follow-up27 Participants
Secondary

Conners Parent Symptom Questionnaire (PSQ)

Conners Parent Symptom Questionnaire (PSQ) is a questionnaire screening for children's behavioral problems (especially with ADHD), it has 48 items(4-stage: 0-3) that can be divided into 6 factors (conduct problems, learning problems, psychosomatic problems, impulsive-hyperactivity, anxiety, and hyperactivity index). Add the scores and divide by the item numbers of each factor to get Z score. Here we mainly observe the changes in Hyperactivity Index (HI) Z scores, it ranges from 0-3, a higher score mean a worse outcome.

Time frame: Baseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.

ArmMeasureGroupValue (MEAN)Dispersion
rTMS GroupConners Parent Symptom Questionnaire (PSQ)Pre-intervention1.20 score on a scaleStandard Deviation 0.49
rTMS GroupConners Parent Symptom Questionnaire (PSQ)Post-intervention1.18 score on a scaleStandard Deviation 0.48
rTMS GroupConners Parent Symptom Questionnaire (PSQ)1month follow-up1.10 score on a scaleStandard Deviation 0.34
Secondary

Peabody Picture Vocabulary Test(PPVT)

The Peabody Picture Vocabulary Test is one of the most commonly used assessment tests for measuring single-word comprehension. The raw score ranges from 0-110, the higher scores mean a better outcome. we collected the PPVT raw score from baseline to 1 months after treatment to evaluate the effect of rTMS treatment on ASD children's words comprehension.

Time frame: Baseline, and 4 weeks after the completion of intervention.

Population: Three subjects did not cooperate with the test, so their data were excluded from the analysis

ArmMeasureGroupValue (MEAN)Dispersion
rTMS GroupPeabody Picture Vocabulary Test(PPVT)Pre-intervention67.78 score on a scaleStandard Deviation 27.23
rTMS GroupPeabody Picture Vocabulary Test(PPVT)1month follow-up76.11 score on a scaleStandard Deviation 26.89
Secondary

Repetitive Behaviors Scale - Revised (RBS-R)

The Repetitive Behaviors Scale - Revised (RBS-R) is a 44-item (rated 0-3) questionnaire that is used to measure the breadth of repetitive behavior in children, adolescents, and adults with Autism Spectrum disorders. The RBS-R provides a quantitative, continuous measure of the full spectrum of repetitive behaviors. The RBS-R consists of six subscales including: Stereotyped Behavior, Self-injurious Behavior, Compulsive Behavior, Routine Behavior, Sameness Behavior, and Restricted Behavior, that have no overlap of item content. Here we use the RBS-R total score, it ranges from 0-132, the higher score means worse repetitive behavior.

Time frame: baseline, immediately after the completion of 5-days intervention, and 4 weeks after the completion of intervention.

ArmMeasureGroupValue (MEDIAN)
rTMS GroupRepetitive Behaviors Scale - Revised (RBS-R)Pre-intervention7.00 score on a scale
rTMS GroupRepetitive Behaviors Scale - Revised (RBS-R)immediately after the completion of Post-intervention7.00 score on a scale
rTMS GroupRepetitive Behaviors Scale - Revised (RBS-R)4 weeks after the completion of 1month follow-up5.5 score on a scale
Other Pre-specified

Multilingual Assessment Instrument for Narratives (MAIN)

For a subset of ASD children with adequate expressive ability (those able to at least use phrases), we use Multilingual Assessment Instrument for Narratives (MAIN) tool to assess their narrative comprehension and production skills. In this test, children were asked to tell and retell the story and answer comprehension questions, and then assessors scored children's performance from four dimensions (i.e., story structure, structural complexity, and internal state terms and comprehension questions). The story structure score range is 0-18, structural complexity score range is 0-4, internal state terms score range is 0-no limit, and comprehension questions score range is 0-10. The higher score means better performance.

Time frame: Baseline, and 4 weeks after the completion of intervention.

Population: 14 children having certain expression ability to complete MAIN test.

ArmMeasureGroupValue (MEAN)Dispersion
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Story Structure_Pre-intervention7.57 score on a scaleStandard Deviation 2.34
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Story Structure_1month follow-up8.96 score on a scaleStandard Deviation 2.43
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Structural Complexity_Pre-intervention2.11 score on a scaleStandard Deviation 0.59
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Structural Complexity_1month follow-up2.50 score on a scaleStandard Deviation 0.55
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Internal States Terms_Pre-intervention3.68 score on a scaleStandard Deviation 2
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Internal States Terms_1month follow-up5.21 score on a scaleStandard Deviation 3.2
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Comprehension Questions_Pre-intervention6.50 score on a scaleStandard Deviation 1.79
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Telling_Comprehension Questions_1month follow-up8.32 score on a scaleStandard Deviation 1.56
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Story Structure_Pre-intervention9.07 score on a scaleStandard Deviation 2.18
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Story Structure_1month follow-up12.21 score on a scaleStandard Deviation 2.28
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Structural Complexity_Pre-intervention2.32 score on a scaleStandard Deviation 0.58
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Structural Complexity_1month follow-up2.75 score on a scaleStandard Deviation 0.38
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Internal States Terms_Pre-intervention5.07 score on a scaleStandard Deviation 2.13
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Internal States Terms_1month follow-up6.14 score on a scaleStandard Deviation 1.56
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Comprehension Questions_Pre-intervention6.46 score on a scaleStandard Deviation 1.96
rTMS GroupMultilingual Assessment Instrument for Narratives (MAIN)Retelling_Comprehension Questions_1month follow-up8.21 score on a scaleStandard Deviation 1.66
Other Pre-specified

Power Spectral Density (PSD) Within the Alpha Frequency Band

For EEG data, we caculated the power spectral density (PSD) within the alpha frequency band (8-13 Hz) for all channels.

Time frame: Baseline, immediately after the completion of 5-days intervention.

Population: We successfully collected EEG data from 26 children before and after the intervention, and one patient was excluded after a quality control procedure. Due to limited implementation conditions (e.g., epidemics, installations) , we did not collect EEG data at 1-month follow-up. The phase locking value(PLV) and coherence (Coh) were not analyzed due to data and analyst issues.

ArmMeasureGroupValue (MEAN)Dispersion
rTMS GroupPower Spectral Density (PSD) Within the Alpha Frequency BandPre-intervention2.05 W/HzStandard Deviation 0.96
rTMS GroupPower Spectral Density (PSD) Within the Alpha Frequency BandPost-intervention1.66 W/HzStandard Deviation 0.67

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026